Cargando…

Targeting M-MDSCs enhances the therapeutic effect of BNCT in the 4-NQO-induced murine head and neck squamous cell carcinoma model

PURPOSE: Malignant head and neck squamous cell carcinoma (HNSCC) is characterized by a poor prognosis and resistance to conventional radiotherapy. Infiltrating myeloid-derived suppressive cells (MDSCs) is prominent in HNSCC and is linked to immune suppression and tumor aggressiveness. This study aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Chun-Hsiang, Chen, Chi-Jui, Yu, Ching-Fang, Tsai, Hui-Yu, Chen, Fang-Hsin, Chiang, Chi-Shiun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598372/ https://www.ncbi.nlm.nih.gov/pubmed/37886177 http://dx.doi.org/10.3389/fonc.2023.1263873

Ejemplares similares

Polymer-Coated Nanoparticles for Therapeutic and Diagnostic Non-(10)B Enriched Polymer-Coated Boron Carbon Oxynitride (BCNO) Nanoparticles as Potent BNCT Drug
por: Chiang, Chen-Wei, et al.
Publicado: (2021)

Association of the GSTP1 and NQO1 Polymorphisms and Head and Neck Squamous Cell Carcinoma Risk
por: Cho, Chang Gun, et al.
Publicado: (2006)

Prevention and early management of carotid blowout syndrome for patients receiving head and neck salvage boron neutron capture therapy (BNCT)
por: Lan, Tien-Li, et al.
Publicado: (2021)

Local Interleukin-12 Treatment Enhances the Efficacy of Radiation Therapy by Overcoming Radiation-Induced Immune Suppression
por: Yu, Ching-Fang, et al.
Publicado: (2021)

Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck
por: Hung, Yu-Hsuan, et al.
Publicado: (2018)

Dual roles of tumour cells-derived matrix metalloproteinase 2 on brain tumour growth and invasion
por: Yu, Ching-Fang, et al.
Publicado: (2017)

Evidence‐searching capability among health care professionals: a comparative study
por: Chi, Szu-Yu, et al.
Publicado: (2021)

Mesoporous Silica Nanoparticle–Based Combination of NQO1 Inhibitor and 5-Fluorouracil for Potent Antitumor Effect Against Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Chen, Jing, et al.
Publicado: (2019)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

Enhanced Chemosensitivity by Targeting Nanog in Head and Neck Squamous Cell Carcinomas
por: Huang, Chuan-En, et al.
Publicado: (2014)

UBE2C triggers HIF‐1α‐glycolytic flux in head and neck squamous cell carcinoma
por: Yang, Yi‐Fang, et al.
Publicado: (2022)

Irradiation Promotes an M2 Macrophage Phenotype in Tumor Hypoxia
por: Chiang, Chi-Shiun, et al.
Publicado: (2012)

Electrostatic quadrupole DC accelerators for BNCT applications
por: Kwan, J W, et al.
Publicado: (1994)

169: DEVELOPMENT OF A SCALE FOR MEASURING EVIDENCE-SEARCHING CAPABILITY: A MODIFIED DELPHI STUDY
por: Chi, Ching-Chi, et al.
Publicado: (2017)

6-shogaol is a potential treatment for Head and Neck Squamous Cell Carcinoma
por: Hsu, Cheng-Ming, et al.
Publicado: (2023)

Radiation Therapy-Induced Tumor Invasiveness Is Associated with SDF-1-Regulated Macrophage Mobilization and Vasculogenesis
por: Wang, Shu-Chi, et al.
Publicado: (2013)

Distinct Tumor Microenvironment at Tumor Edge as a Result of Astrocyte Activation Is Associated With Therapeutic Resistance for Brain Tumor
por: Lin, Chiu-Min, et al.
Publicado: (2019)

The Roles of Macrophages and Nitric Oxide in Interleukin-3-Enhanced HSV-Sr39tk-Mediated Prodrug Therapy
por: Yu, Ching-Fang, et al.
Publicado: (2013)

MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma
por: Chen, Li-Hsin, et al.
Publicado: (2010)

Discovery of Isoplumbagin as a Novel NQO1 Substrate and Anti-Cancer Quinone
por: Tsao, Yen-Chi, et al.
Publicado: (2020)

Advances in Boron Neutron Capture Therapy (BNCT) for Recurrent Intracranial Meningioma
por: Lan, Tien-Li, et al.
Publicado: (2023)

Cuproptosis-related gene subtypes predict prognosis in patients with head and neck squamous cell carcinoma
por: Wang, Chi, et al.
Publicado: (2023)

Nutritional Stress in Head and Neck Cancer Originating Cell Lines: The Sensitivity of the NRF2-NQO1 Axis
por: Milković, Lidija, et al.
Publicado: (2019)

Clinical Veterinary Boron Neutron Capture Therapy (BNCT) Studies in Dogs with Head and Neck Cancer: Bridging the Gap between Translational and Clinical Studies
por: Schwint, Amanda E., et al.
Publicado: (2020)

Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior
por: Chien, Chih-Yen, et al.
Publicado: (2014)

Introduction to the Monte Carlo dose engine COMPASS for BNCT
por: Zhong, Wan-Bing, et al.
Publicado: (2023)

Dihydroisotanshinone I as a Treatment Option for Head and Neck Squamous Cell Carcinomas
por: Hsu, Cheng-Ming, et al.
Publicado: (2021)

Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin
por: Hsieh, Chen-Hsi, et al.
Publicado: (2013)

A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications
por: Chi, Li-Hsing, et al.
Publicado: (2021)

5-Methoxytryptophan Sensitizing Head and Neck Squamous Carcinoma Cell to Cisplatitn Through Inhibiting Signal Transducer and Activator of Transcription 3 (STAT3)
por: Su, Yu-Chieh, et al.
Publicado: (2022)

Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis
por: Chang, Yu-Chan, et al.
Publicado: (2017)

Treatment Planning Systems for BNCT: Requirements and Peculiarities
por: Daquino, G G
Publicado: (2003)

Dose Rate Effect on Cell Survival in BNCT
por: Hirose, Katsumi, et al.
Publicado: (2023)

Association between Phosphorylated AMP-Activated Protein Kinase and Acetyl-CoA Carboxylase Expression and Outcome in Patients with Squamous Cell Carcinoma of the Head and Neck
por: Su, Ying-Wen, et al.
Publicado: (2014)

Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Hsieh, Ching-Yun, et al.
Publicado: (2023)

Microsatellite alteration in head and neck squamous cell carcinoma patients from a betel quid-prevalent region
por: Lin, Jin-Ching, et al.
Publicado: (2016)

Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
por: Chen, Wen-Chun, et al.
Publicado: (2017)

Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma
por: Chou, Ming-Huei, et al.
Publicado: (2021)

HU-based material conversion for BNCT accurate dose estimation
por: Teng, Yi-Chiao, et al.
Publicado: (2023)

Expression and regulatory network of miRNAs in head and neck squamous cell carcinoma
por: Zhao, Lei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_96d9kmtb10477qclkoh3tlv8rc